bpc 157 joe rogan podcast and Gary Brecka dive into the FDA's reclassification of peptides, with lots of F-bombs along the way. Tune in to hear Gary's thoughts on why the FDA is doing this 502 - Dr. Rhonda Patrick

TB-500 addresses inflammation through microRNA-146a upregulation, a mechanism entirely separate from Retatrutides metabolic pathways

doi:10.1111/jth.13741 Prevention

Many patients taking long-term metformin, proton pump inhibitors (PPIs) or H antagonists may be at increased risk of B12 deficiency due to impaired absorption

A recent review in the American Journal of Sports Medicine summed up the orthopedic and sports-medicine evidence: While peptide therapy may possess significant therapeutic and regenerative potential, it is critical that orthopaedic and sports medicine providers understand the current lack of evidence to support the clinical use of these peptides, the authors said